Imagen de Portada
Código QR

Body composition unchanged after advanced PCa Tx.

Publicado en:Urology Times Vol. 41; no. 13; pp. 6 - 8
Autor principal: Kuznar, Wayne
Formato: Journal Article
Publicado: MJH Life Sciences 12/1/2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109866099&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109866099
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: 12/1/2013
      vid: 41
      iid: 13
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        109866099
        2013033313
        109866099
      ppf: 6
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Body composition unchanged after advanced PCa Tx.
      aug:
        au: Kuznar, Wayne
      sug:
        subj:
          Body Composition Drug Effects
          Prostatic Neoplasms Drug Therapy
          Abiraterone Acetate Pharmacodynamics
          Androgen Antagonists Pharmacodynamics
          Neoplasm Metastasis Drug Therapy
          Abdominal Fat
          Muscle, Skeletal
          Sarcopenia
          Placebos
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N